By opting in to the Pharma in silica SMS program, you agree to receive recurring promotional SMS/text messages from Laboratories Pharma in silica inc. Messages may include company updates, investor communications, investment opportunities, newsletters, event or meeting follow-ups, and related information.
You may opt in through our website or through another documented written interaction with Pharma in silica, including email, LinkedIn, or communications associated with conferences, presentations, meetings, events, or other direct interactions, provided that you expressly agree to receive SMS/text messages and provide your mobile telephone number for that purpose. Participation in the SMS program is voluntary. Consent to receive SMS/text messages is not a condition of any purchase, investment, or other transaction.
Message frequency varies.
Message and data rates may apply depending on your mobile carrier and service plan.
You may unsubscribe from SMS/text messages at any time by replying STOP to any message. After an opt-out request, you will no longer receive promotional SMS/text messages from this program unless you subsequently opt in again.
For assistance, reply HELP to any SMS/text message or contact Pharma in silica at arcandf@pharma-insilica.com.
Mobile telephone numbers, SMS opt-in data, and SMS consent information will not be sold, rented, or shared with third parties or affiliates for their own marketing or promotional purposes. Such information may be processed by service providers solely as necessary to operate and deliver Pharma in silica’s messaging services and in accordance with our instructions. For additional information about how Pharma in silica collects, uses, retains, and protects personal information, please review our Privacy Policy.
Laboratories Pharma in silica inc.
2500 boul. du Parc-Technologies
Quebec, Qc Canada G1P 4S6
arcandf@pharma-insilica.com